Biotech SF
San Francisco Bay Area biotech stories.
Monday, October 3, 2011
Xoma scores botulism grant valued at $28M over five years
Xoma Ltd. will develop a treatment for human botulism poisoning under a federal contract that could pay out $28 million over five years.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment